Telomir Pharmaceuticals
TELO
#8546
Rank
C$0.20 B
Marketcap
$6.76
Share price
-9.56%
Change (1 day)
N/A
Change (1 year)

EPS for Telomir Pharmaceuticals (TELO)

EPS in 2023 (TTM): -$0.16

According to Telomir Pharmaceuticals's latest financial reports the company's current EPS (TTM) is -$0.17. In 2022 the company made an earnings per share (EPS) of -$0.04161 a decrease over its 2021 EPS that were of -$0.006729.

EPS history for Telomir Pharmaceuticals from 2021 to 2023

Annual EPS

Year EPS Change
2023 (TTM)-$0.16288.75%
2022-$0.04161518.37%
2021-$0.006729